Health care industry
Anthropic launches Claude Life Sciences to give researchers an AI efficiency boost
Dario Amodei, Anthropic CEO, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 21st, 2025. Gerry Miller | CNBC Anthropic on Monday announced Claude for Life Sciences, a new offering for researchers to use the company’s artificial intelligence technology in the advancement of scientific discovery. Claude for Life Sciences is […]
Read More
Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price. “In London, you’d buy a certain drug for $130 and even less than that … $88 […]
Read More
Trump announces efforts to expand access to IVF drugs
U.S. President Donald Trump delivers remarks before signing an executive order on expanding access to IVF at his Mar-a-Lago resort on Feb. 18, 2025 in Palm Beach, Florida. Joe Raedle | Getty Images President Donald Trump on Thursday announced two new efforts to expand the availability of in vitro fertilization, the first concrete step from his […]
Read More
Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers
A sign is posted in front of a Genentech office on June 12, 2025 in South San Francisco, California. Justin Sullivan | Getty Images Roche‘s Genentech on Thursday said it will sell its flu pill, Xofluza, directly to certain patients at a discount in a bid to expand access, becoming the latest company to wade […]
Read More
DuPont prepares to say goodbye to electronics. What investors get with the remaining company
Earlier in the week, we looked at the upcoming DuPont electronics business spinoff and what investors are getting with the new Qnity Electronics, which has a strong foothold in the semiconductor industry. Now, here is a look at what will be left of the new DuPont after the planned Nov. 1 split and the stocks […]
Read More
CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
Key Points Wells Fargo CEO Charlie Scharf said AI is boosting productivity but will likely reduce workforce size. Pfizer CEO Albert Bourla warned China is closing the biotech and pharmaceutical patent gap rapidly and said the U.S. needs to focus on innovation. Speaking at CNBC’s inaugural Invest in America Forum, both CEOs agreed that the […]
Read More
Democratic governors form a public health alliance in rebuke of Trump administration
US Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. speaks about the sending of warning letters to companies for illegally marketing products containing 7-hydroxymitragynine, also known as 7-OH, as part of their actions combatting opioids, during a press conference at HHS headquarters in Washington, DC, on July 29, 2025. Saul Loeb | Afp […]
Read More
Abbott’s quarter disappoints again: We’re downgrading it and considering what to do next
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue in the third quarter ended Sept. 30 rose 6.9% to $11.37 billion, missing the $11.4 billion consensus estimate compiled by market data provider LSEG. Organic sales , excluding Covid testing results, rose 7.5%, beating the 5.9% estimate, […]
Read More
Higher education CEO on AI’s growing role in health-care degree market
AI is quickly transforming the way companies and CEOs are approaching their businesses and the strategies that take them forward. Amid that rapid transformation, Adtalem Global Education CEO Steve Beard said there is a “threshold question” that he keeps coming back to. “That question is, is AI a complement for what you do, or is […]
Read More
J&J to spin off orthopedics business, raises full-year forecast
Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The health-care conglomerate also raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations. The company […]
Read More